Form 4 · BMY
Bristol Myers Squibb director Julia A. Haller reports selling 3,800 shares
Julia A. Haller, a Bristol Myers Squibb director, filed a Form 4 on Nov 6, 2026 at 4:25 PM ET reporting transactions on Nov 5, 2026.
The filing reports 3,800 shares in an open-market or private sale (code S) at $63.31, about $240,578 in total.
The filing does not indicate that the sales were made under a Rule 10b5-1 trading plan.
After these transactions, the filing lists 30,279 shares of Common Stock, $0.10 par value held directly.
Effect on holdings
Taken together, the rows reported here lowered Julia A. Haller's directly held shares by 11.2%, from 34,079 to 30,279.
Reporting person
- Julia A. Haller, director (as filed: Haller Julia A)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-05 | S | Common Stock, $0.10 par value | 3,800 | $63.31 | Disposed | 30,279 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 6, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Bristol Myers Squibb company file → · More Bristol Myers Squibb filings
Disclosures
- Editor holdings in BMY
- The editor holds no position in Bristol Myers Squibb (BMY). As of Nov 11, 2026.
- Last updated
- Nov 6, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold BMY.